Invokana and Diabetic neuropathic ulcer - a phase IV clinical study of FDA data
Summary:
Diabetic neuropathic ulcer is reported as a side effect among people who take Invokana (canagliflozin), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months and have Pain.
The phase IV clinical study analyzes which people have Diabetic neuropathic ulcer when taking Invokana. It is created by eHealthMe based on reports of 29,682 people who have side effects when taking Invokana from the FDA, and is updated regularly.
What is Invokana?
Invokana has active ingredients of canagliflozin. It is often used in diabetes. eHealthMe is studying from 29,937 Invokana users. Check the latest studies of Invokana.
What is Diabetic neuropathic ulcer?
Diabetic neuropathic ulcer (development of diabetic foot ulcers) is found to be associated with 18 drugs and 22 conditions by eHealthMe. Check the latest studies of Diabetic neuropathic ulcer.
29,682 people reported to have side effects when taking Invokana.
Among them, 11 people (0.04%) have Diabetic neuropathic ulcer.
Among these 11 people:
How long have people been on Invokana when they have Diabetic neuropathic ulcer? *
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Diabetic neuropathic ulcer when taking Invokana? *
- female: 27.27 %
- male: 72.73 %
What is the age of people who have Diabetic neuropathic ulcer when taking Invokana? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 9.09 %
- 40-49: 18.18 %
- 50-59: 45.45 %
- 60+: 27.27 %
What are other side effects people have besides Diabetic neuropathic ulcer? *
- Osteomyelitis (infection of bone): 9 people, 81.82%
- Diabetic Foot Infection: 5 people, 45.45%
- Gangrene (body tissue dies): 2 people, 18.18%
- Foot Amputation (loss of foot): 2 people, 18.18%
- Cellulitis (infection under the skin): 2 people, 18.18%
- Postoperative Wound Infection: 1 person, 9.09%
- Pancreatitis Acute (sudden inflammation of pancreas): 1 person, 9.09%
- Localised Infection (infection at the single location): 1 person, 9.09%
- Blockage Of Leg Arteries: 1 person, 9.09%
- Abscess Limb (limb infection): 1 person, 9.09%
What are the existing conditions these people have? *
- Pain: 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Invokana and have Diabetic neuropathic ulcer?
- Check whether Diabetic neuropathic ulcer is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Invokana:
- Invokana (29,937 reports)
Diabetic neuropathic ulcer treatments and more:
- Diabetic neuropathic ulcer (30 reports)
How severe was Diabetic neuropathic ulcer and when was it recovered:
Expand to all the drugs that have ingredients of canagliflozin:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Invokana:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Diabetic neuropathic ulcer:
- Diabetic neuropathic ulcer (18 drugs)
Browse all the conditions that are associated with Diabetic neuropathic ulcer:
- Diabetic neuropathic ulcer (22 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on canagliflozin (the active ingredients of Invokana) and Invokana (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Senna cause Hypotension? - 13 seconds ago
- Tekturna Hct vs. Metformin Hydrochloride, side effect and effectiveness comparison - 14 seconds ago
- Drug interactions of Minocycline Hydrochloride and Valacyclovir - 17 seconds ago
- Drug interactions of Hctz and Soliris - 26 seconds ago
- Drug interactions of Zoloft and Hydroxyzine Pamoate - 29 seconds ago
- Could Docetaxel cause Muscle Spasms? - 31 seconds ago
- Drug interactions of Repatha and Sertraline - 35 seconds ago
- Drug interactions of Naftin and Bactroban - 37 seconds ago
- Losartan vs. Amvaz, side effect and effectiveness comparison - 51 seconds ago
- Diabetes and Genital Rash - 51 seconds ago